Series A · BiotechStarget Pharma: Series ADevelops next-generation peptide radioligand therapies for cancerPublished Oct 4, 2026By RoundOS Funding deskFunding historyFeb 18, 2026Series A · This round$18MSourcesprnewswire.com↗
Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.UndisclosedSeed · Oct 23, 2026
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200MPrivate financing · Oct 23, 2026
Yizhu TechnologyYizhu Technology designs compute-in-memory chips for AI inference and post-training workloads.>CN¥1BUndisclosed · Oct 23, 2026
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237MSeries E · Oct 23, 2026